Publications by authors named "B Monroe"

Incidence of human monkeypox (mpox) has been increasing in West and Central Africa, including in the Democratic Republic of Congo (DRC), where monkeypox virus (MPXV) is endemic. Most estimates of the pathogen's transmissibility in the DRC are based on data from the 1980s. Amid the global 2022 mpox outbreak, new estimates are needed to characterize the virus' epidemic potential and inform outbreak control strategies.

View Article and Find Full Text PDF

Background: Rabies expert on demand (REOD) telehealth service is provided by the U.S. Centers for Disease Control and Prevention (CDC) to assist public health practitioners, health providers, and the public to interpret national and international rabies prevention guidelines.

View Article and Find Full Text PDF

Background And Objectives: The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) provides food and other resources to mitigate the harmful effects of food insecurity on child and maternal health. From a 2009 peak, nationwide WIC participation declined through 2020. Our objectives were to understand factors influencing WIC engagement and improve WIC enrollment through novel, primary care-based quality improvement interventions.

View Article and Find Full Text PDF

The current worldwide monkepox outbreak has reaffirmed the continued threat monkeypox virus (MPXV) poses to public health. JYNNEOS, a Modified Vaccinia Ankara (MVA)-based live, non-replicating vaccine, was recently approved for monkeypox prevention for adults at high risk of MPXV infection in the United States. Although the safety and immunogenicity of JYNNEOS have been examined previously, the clinical cohorts studied largely derive from regions where MPXV does not typically circulate.

View Article and Find Full Text PDF
Article Synopsis
  • Monkeypox is a rare zoonotic infection mainly found in west and central Africa, caused by the Monkeypox virus, which is related to the smallpox virus.
  • After nearly four decades without cases in Nigeria, a significant outbreak occurred between 2017-2018, resulting in 118 confirmed infections, followed by sporadic cases, including six diagnoses in non-African countries between 2018 and 2021.
  • In July 2021, a traveler from Nigeria to Texas was diagnosed with monkeypox, with 74% of monitored contacts being flight contacts; the patient was treated with an antiviral and required decontamination, but the exact source of the infection remains unidentified.
View Article and Find Full Text PDF